| Surviving sepsis campaign international guidelines for the management of septic shock and sepsis-associated organ dysfunction in children SL Weiss, MJ Peters, W Alhazzani, MSD Agus, HR Flori, DP Inwald, ... Intensive care medicine 46, 10-67, 2020 | 2053 | 2020 |
| Strategies to prevent central line-associated bloodstream infections in acute-care hospitals: 2022 Update N Buetti, J Marschall, M Drees, MG Fakih, L Hadaway, LL Maragakis, ... Infection Control & Hospital Epidemiology 43 (5), 553-569, 2022 | 476 | 2022 |
| SARS-CoV-2 mRNA vaccination elicits a robust and persistent T follicular helper cell response in humans PA Mudd, AA Minervina, MV Pogorelyy, JS Turner, W Kim, E Kalaidina, ... Cell 185 (4), 603-613. e15, 2022 | 319 | 2022 |
| Consensus guidelines for diagnosis, prophylaxis and management of Pneumocystis jirovecii pneumonia in patients with haematological and solid malignancies … L Cooley, C Dendle, J Wolf, BW Teh, SC Chen, C Boutlis, KA Thursky Internal medicine journal 44 (12b), 1350-1363, 2014 | 274 | 2014 |
| Flash survey on severe acute respiratory syndrome coronavirus-2 infections in paediatric patients on anticancer treatment O Hrusak, T Kalina, J Wolf, A Balduzzi, M Provenzi, C Rizzari, S Rives, ... European Journal of Cancer 132, 11-16, 2020 | 237 | 2020 |
| Infection-related complications during treatment for childhood acute lymphoblastic leukemia H Inaba, D Pei, J Wolf, SC Howard, RT Hayden, M Go, O Varechtchouk, ... Annals of Oncology 28 (2), 386-392, 2017 | 227 | 2017 |
| SARS-CoV-2 antigen exposure history shapes phenotypes and specificity of memory CD8+ T cells AA Minervina, MV Pogorelyy, AM Kirk, JC Crawford, EK Allen, CH Chou, ... Nature immunology 23 (5), 781-790, 2022 | 219 | 2022 |
| Gut microbiome composition predicts infection risk during chemotherapy in children with acute lymphoblastic leukemia H Hakim, R Dallas, J Wolf, L Tang, S Schultz-Cherry, V Darling, ... Clinical Infectious Diseases 67 (4), 541-548, 2018 | 207 | 2018 |
| Multicenter initial guidance on use of antivirals for children with coronavirus disease 2019/severe acute respiratory syndrome coronavirus 2 K Chiotos, M Hayes, DW Kimberlin, SB Jones, SH James, SG Pinninti, ... Journal of the Pediatric Infectious Diseases Society 9 (6), 701-715, 2020 | 188 | 2020 |
| The Michigan appropriateness guide for intravenous catheters in pediatrics: miniMAGIC AJ Ullman, SJ Bernstein, E Brown, R Aiyagari, D Doellman, EVS Faustino, ... Pediatrics 145 (Supplement_3), S269-S284, 2020 | 188 | 2020 |
| Guideline for the management of fever and neutropenia in pediatric patients with cancer and hematopoietic cell transplantation recipients: 2023 update T Lehrnbecher, PD Robinson, RA Ammann, B Fisher, P Patel, R Phillips, ... Journal of clinical oncology 41 (9), 1774, 2023 | 182 | 2023 |
| Venetoclax in combination with cytarabine with or without idarubicin in children with relapsed or refractory acute myeloid leukaemia: a phase 1, dose-escalation study SE Karol, TB Alexander, A Budhraja, SB Pounds, K Canavera, L Wang, ... The lancet oncology 21 (4), 551-560, 2020 | 174 | 2020 |
| Guideline for antibacterial prophylaxis administration in pediatric cancer and hematopoietic stem cell transplantation T Lehrnbecher, BT Fisher, B Phillips, S Alexander, RA Ammann, ... Clinical Infectious Diseases 71 (1), 226-236, 2020 | 157 | 2020 |
| Multicenter interim guidance on use of antivirals for children with coronavirus disease 2019/severe acute respiratory syndrome coronavirus 2 K Chiotos, M Hayes, DW Kimberlin, SB Jones, SH James, SG Pinninti, ... Journal of the Pediatric Infectious Diseases Society 10 (1), 34-48, 2021 | 156 | 2021 |
| Evaluation of plasma microbial cell-free DNA sequencing to predict bloodstream infection in pediatric patients with relapsed or refractory cancer KP Goggin, V Gonzalez-Pena, Y Inaba, KJ Allison, DK Hong, AA Ahmed, ... JAMA oncology 6 (4), 552-556, 2020 | 148 | 2020 |
| Pre-existing humoral immunity to human common cold coronaviruses negatively impacts the protective SARS-CoV-2 antibody response CY Lin, J Wolf, DC Brice, Y Sun, M Locke, S Cherry, AH Castellaw, ... Cell host & microbe 30 (1), 83-96. e4, 2022 | 119 | 2022 |
| Clinical Pharmacogenetics Implementation Consortium Guideline for the Use of Aminoglycosides Based on MT‐RNR1 Genotype JH McDermott, J Wolf, K Hoshitsuki, R Huddart, KE Caudle, ... Clinical Pharmacology & Therapeutics 111 (2), 366-372, 2022 | 107 | 2022 |
| Levofloxacin prophylaxis during induction therapy for pediatric acute lymphoblastic leukemia J Wolf, LI Tang, PM Flynn, CH Pui, AH Gaur, Y Sun, H Inaba, T Stewart, ... Clinical Infectious Diseases 65 (11), 1790-1798, 2017 | 106 | 2017 |
| RelA Mutant Enterococcus faecium with Multiantibiotic Tolerance Arising in an Immunocompromised Host ES Honsa, VS Cooper, MN Mhaissen, M Frank, J Shaker, A Iverson, ... MBio 8 (1), 10.1128/mbio. 02124-16, 2017 | 101 | 2017 |
| Executive summary: surviving sepsis campaign international guidelines for the management of septic shock and sepsis-associated organ dysfunction in children SL Weiss, MJ Peters, W Alhazzani, MSD Agus, HR Flori, DP Inwald, ... Intensive care medicine 46, 1-9, 2020 | 98 | 2020 |
